November 2026
1. CHENG M, Li W, Liu M, Zou L, et al
   Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives.
   Int J Cancer. 2026;159:2111-2126.
   

   >> Share

   
   April 2026
2. MATOS A, Cawthorn WP, Marinho-Dias J, Ramalheira S, et al
   Systemic and Local Adiposity in the Bone Marrow Microenvironment Associated With Improved Prognosis in Hodgkin Lymphoma: Imaging and Molecular Analysis.
   Int J Cancer. 2026 Apr 20. doi: 10.1002/ijc.70480.
   

   >> Share

   
   
3. WANG H, Li J, Cao L, Zhang Y, et al
   Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.
   Int J Cancer. 2026 Apr 18. doi: 10.1002/ijc.70507.
   

   >> Share

   
   
4. ZIEL-SWIER LJYM, Rassek K, Liu Y, Seitz A, et al
   The Growth Supporting Role of ZDHHC11 Is Linked to the MEF2B-BCL6 Regulatory Circuit in Burkitt Lymphoma.
   Int J Cancer. 2026 Apr 16. doi: 10.1002/ijc.70506.
   

   >> Share

   
   
5. HIRABAYASHI M, Georges D, Combes JD, Clifford GM, et al
   Attributable Fraction of Epstein-Barr Virus in Subtypes of Lymphoma: A Systematic Review and Global Meta-Analysis.
   Int J Cancer. 2026 Apr 7. doi: 10.1002/ijc.70468.
   

   >> Share

   
   January 2026
6. ZUPUNSKI L, Yaumenenka A, Veyalkin I, Minenko V, et al
   Lymphoma, multiple myeloma and leukaemia incidence in regions of Belarus most heavily contaminated by the Chernobyl accident.
   Int J Cancer. 2026 Jan 23. doi: 10.1002/ijc.70346.
   

   >> Share

   
   
7. LI D, Li N, Huang S, Zhang M, et al
   Low T3 syndrome in children with aggressive mature B-cell non-Hodgkin lymphoma.
   Int J Cancer. 2026 Jan 17. doi: 10.1002/ijc.70335.
   

   >> Share

   
   December 2025
8. ROSTGAARD K, Hamilton-Dutoit S, Lauridsen KL, Ottander L, et al
   Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.
   Int J Cancer. 2025 Dec 25. doi: 10.1002/ijc.70305.
   

   >> Share

   
   November 2025
9. WANG X, Yang W, Xing H, Wang X, et al
   The efficacy and survival impact of chidamide on angioimmunoblastic T-cell lymphoma based on Epstein-Barr virus stratification in the real world: A multicenter study.
   Int J Cancer. 2025 Nov 20. doi: 10.1002/ijc.70251.
   

   >> Share

   
   
10. EKBERG S, Glimelius I, Albertsson-Lindblad A, Smedby KE, et al
    Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma.
    Int J Cancer. 2025 Nov 5. doi: 10.1002/ijc.70220.
    

    >> Share

    
    
11. BARNA G, Szaloki G, Mark A, Hunyadi A, et al
    CD86, the double agent: Significance of CD86 expression in B-cell malignancies.
    Int J Cancer. 2025;157:1772-1780.
    

    >> Share

    
    October 2025
12. QIU L, Bai S, Cai J, Fang Y, et al
    Antiviral prophylaxis for hepatitis B virus reactivation in T-cell lymphoma patients with resolved hepatitis B virus infection.
    Int J Cancer. 2025 Oct 4. doi: 10.1002/ijc.70186.
    

    >> Share

    
    September 2025
13. RAMASSAMY JL, Tortevoye P, Ntab B, Carles G, et al
    Adult T-cell leukemia/lymphoma in French Guiana (1990-2019): Epidemiology, clinical features, and HTLV-1 genetic diversity in the two main ethnic populations.
    Int J Cancer. 2025 Sep 23. doi: 10.1002/ijc.70164.
    

    >> Share

    
    
14. MOORE A, Kane E, Teras LR, Machiela MJ, et al
    Genetically determined body mass index is associated with diffuse large B-cell lymphoma in polygenic and Mendelian randomization analyses.
    Int J Cancer. 2025 Sep 5. doi: 10.1002/ijc.70039.
    

    >> Share

    
    August 2025
15. ZHAO J, Zhang Y, Li K, Xu L, et al
    Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study.
    Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70115.
    

    >> Share

    
    
16. LOPES-ARAUJO HF, Guimaraes RL, Carvalho-Silva WHV
    Correlations between new HIV infections and hospital admissions for non-Hodgkin lymphoma in Brazil.
    Int J Cancer. 2025 Aug 6. doi: 10.1002/ijc.70076.
    

    >> Share

    
    June 2025
17. LIU Y, Lin N, Yi S, Huang H, et al
    Pirtobrutinib in Chinese patients with relapsed or refractory B-cell malignancies: A single-arm, open-label, phase 2, multicenter trial.
    Int J Cancer. 2025;156:2158-2168.
    

    >> Share

    
    March 2025
18. DING J, Cheng X, Wang H, Sun Y, et al
    Prognosis prediction in non-Hodgkin lymphoma by assessing lymphoid organs uptake patterns using baseline (18)F-FDG PET/CT.
    Int J Cancer. 2025 Mar 24. doi: 10.1002/ijc.35412.
    

    >> Share

    
    
19. LIANG X, Wu Y, Lu W, Li T, et al
    Latent class analysis-derived classification improves the cancer-specific death stratification of lymphomas: A large retrospective cohort study.
    Int J Cancer. 2025;156:1131-1141.
    

    >> Share

    
    
20. KIM IE JR, Oduor C, Stamp J, Luftig MA, et al
    Incorporation of Epstein-Barr viral variation implicates significance of Latent Membrane Protein 1 in survival prediction and prognostic subgrouping in Burkitt lymphoma.
    Int J Cancer. 2025 Mar 6. doi: 10.1002/ijc.35384.
    

    >> Share

    
    October 2024
21. JAIN R, Huda TI, Paul S, Chobrutskiy A, et al
    Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphoma.
    Int J Cancer. 2024 Oct 8. doi: 10.1002/ijc.35212.
    

    >> Share

    
    September 2024
22. DUELL J, Westin J
    The future of immunotherapy for diffuse large B-cell lymphoma.
    Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35156.
    

    >> Share

    
    
23. BASSIG BA, Shu XO, Friesen MC, Vermeulen R, et al
    Occupational exposure to benzene and risk of non-Hodgkin lymphoma in an extended follow-up of two population-based prospective cohorts of Chinese men and women.
    Int J Cancer. 2024 Sep 2. doi: 10.1002/ijc.35095.
    

    >> Share

    
    August 2024
24. DUSINGIZE JC, Murenzi G, Muhoza B, Businge L, et al
    Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda from 2007 to 2018.
    Int J Cancer. 2024 Aug 11. doi: 10.1002/ijc.35091.
    

    >> Share

    
    July 2024
25. SARATHKUMARA YD, Xian RR, Liu Z, Yu KJ, et al
    A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.
    Int J Cancer. 2024 Jul 12. doi: 10.1002/ijc.35072.
    

    >> Share

    
    May 2024
26. FEDELI U, Barbiellini Amidei C, Han X, Jemal A, et al
    Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
    Int J Cancer. 2024;154:1703-1708.
    

    >> Share

    
    March 2024
27. WANG X, Deng L, Ping L, Shi Y, et al
    Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34892.
    

    >> Share

    
    
28. TABORELLI M, Serraino D, Cimaglia C, Furian L, et al
    Cancer mortality after kidney transplantation: A multicenter cohort study in Italy.
    Int J Cancer. 2024;154:842-851.
    

    >> Share

    
    December 2023
29. LUO J, Hendryx M, Rohan TE, Saquib N, et al
    Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma.
    Int J Cancer. 2023 Dec 19. doi: 10.1002/ijc.34820.
    

    >> Share

    
    October 2023
30. DU Y, Wang Y, Li Q, Chang X, et al
    Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
    Int J Cancer. 2023 Oct 24. doi: 10.1002/ijc.34773.
    

    >> Share

    
    September 2023
31. LINDMARK G, Olsson L, Sitohy B, Israelsson A, et al
    qRT-PCR analysis of CEACAM5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes-An improved method for assessment of tumor stage and prognosis.
    Int J Cancer. 2023 Sep 12. doi: 10.1002/ijc.34718.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share